Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.936
-0.042 (-2.12%)
Sep 2, 2026, 5:29 PM CET
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 1.22 billion as of September 2, 2026. Its market cap has increased by 458.82% in one year.
Market Cap
1.22B
Enterprise Value
973.28M
Revenue
8.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.94
ChartMarket Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 1.22B, an increase of 90.06%. That is a compound annual growth rate of 2.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.22B | 566.07% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 3.01B |
| Saniona AB | 1.58B |
| Flerie AB | 1.56B |
| BioInvent International AB | 1.50B |
| Genovis AB (publ.) | 1.49B |
| SynAct Pharma AB | 1.12B |
| AlzeCure Pharma AB | 1.09B |
| Infant Bacterial Therapeutics AB | 847.35M |